Sebastien Lobet Presented the ACTIVLIM-Hemo Scale
Sebastien Lobet, PhD at Saint-Luc University Clinics Cliniques, Co-founder of Activlim-Hemo, shared on LinkedIn:
”I had the honor of being invited to the Nordic Baltic Haemophilia Nurse and Physiotherapy Meeting, held over the past two days in Oslo.
I presented the ACTIVLIM-Hemo scale, a tool to assess activity limitations in adults with haemophilia, developed using a robust Rasch-based methodology.
The scale is unidimensional, linear, and reproducible, providing a reliable measure of functional performance.
ACTIVLIM-Hemo has been translated into 11 languages, with 5 already available.
It is freely accessible to all clinicians wishing to evaluate their patients’ activity limitations.
Developed by Prof. Massimo Penta (Arsalis and UCLouvain) and the Haematology Department of the Saint-Luc University Clinics Cliniques.
References:
Lobet S et al., Haemophilia, 2024. DOI: 10.1111/hae.14954
Lobet S et al., Haemophilia, 2023. DOI: 10.1111/hae.14705”
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch